Effectiveness of Copaxone in patients with relapsing-remitting multiple sclerosis
We investigated the effectiveness of Copaxone in patients with relapsing-remitting multiple sclerosis for 3 and 5 years. Significant improvement found the decrease of the frequency of clinical exacerbations and delay the accumulation of physical disability during treatment period.
Main Authors: | , , |
---|---|
Format: | Article |
Sprog: | English |
Udgivet: |
Siberian State Medical University (Tomsk)
2010-08-01
|
Serier: | Бюллетень сибирской медицины |
Fag: | |
Online adgang: | https://bulletin.ssmu.ru/jour/article/view/1618 |